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Abstract: Peptic ulcers are a common disorder of the entire gastrointestinal tract that 
occurs mainly in the stomach and the proximal duodenum. This disease is multifactorial 
and its treatment faces great difficulties due to the limited effectiveness and severe side 
effects of the currently available drugs. The use of natural products for the prevention and 
treatment of different pathologies is continuously expanding throughout the world. This is 
particularly true with regards to flavonoids, which represent a highly diverse class of 
secondary metabolites with potentially beneficial human health effects that is widely 
distributed in the plant kingdom and currently consumed in large amounts in the diet. They 
display several pharmacological properties in the gastroprotective area, acting as 
anti-secretory, cytoprotective and antioxidant agents. Besides their action as 
gastroprotectives, flavonoids also act in healing of gastric ulcers and additionally these 
polyphenolic compounds can be new alternatives for suppression or modulation of peptic 
ulcers associated with H. pylori. In this review, we have summarized the literature on 
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ninety-five flavonoids with varying degrees of antiulcerogenic activity, confirming that 
flavonoids have a therapeutic potential for the more effective treatment of peptic ulcers. 
Keywords: Flavonoids; Gastroprotective activity; Peptic ulcers; Natural products.  
 
Introduction  
Peptic ulcers are a common disorder of the entire gastrointestinal tract [1]. They occur mainly in the 
stomach and the proximal duodenum. They can also occur in the esophagus, jejunum and gastric 
anastamotic site [2]. A peptic ulcer results from an imbalance between some endogenous aggressive 
factor(s) [hydrochloric acid, pepsin, refluxed bile, leukotrienes, reactive oxygen species (ROS)] and 
cytoprotective factors, which include the function of the mucus-bicarbonate barrier, surface active 
phospholipids, prostaglandins (PGs), mucosal blood flow, cell renewal and migration, nonenzymatic 
and enzymatic antioxidants and some growth factors [3-6]. The pathogenesis of gastric ulcers remains 
widespread, it is multifactorial disease where diverse factors such as a stressful lifestyle, alcohol 
consumption, use of steroidal and nonsteroidal antiinflammatory drugs (NSAIDs) and drugs which 
stimulate gastric acid and pepsin secretion, Helicobacter pylori infections, smoking, lower 
socio-economic status and family history all represent significant risk factors that may contribute to 
increasing gastric damage [3]. The prevention or cure of peptic ulcers is one of the most important 
challenges confronting medicine nowadays, as it is certainly a major human illness affecting nearly 8 
to 10 % of the global population [7], and of these 5% suffer from gastric ulcers [3]. The prevalence of 
this disease is higher in men than in women [8]. 
Although recent advances in our understanding have highlighted the multifactorial pathogenesis of 
peptic ulcers, secretion of gastric acid is still recognized as a central component of this disease, 
therefore the main therapeutic target is the control of this secretion using antacids, H2 receptor 
blockers like ranitidine, famotidine, anticholinergics like pirenzepin, telezipine or proton pump 
blockers like omeprazole, lansoprazole, etc. [9]. However, gastric ulcer therapy faces nowadays a 
major drawback because most of the drugs currently available in the market show limited efficacy 
against gastric diseases and are often associated with severe side effects [10,11].  
In this context, the use of medicinal plants is in continuous expansion all over the world for the 
prevention and treatment of different pathologies, and natural products are recovering space and 
importance in the pharmaceutical industry as inspiring sources of new potentially bioactive molecules 
[12]. Clinical research has confirmed the efficacy of several plants for the treatment of gastroduodenal 
diseases [13,14]. The medicinal properties of many plants are attributed mainly to the presence of 
flavonoids, but they may be also influenced by other organic and inorganic compounds such as 
coumarins, alkaloids, terpenoids, tannins, phenolic acids and antioxidant micronutrients, e.g., Cu, Mn, 
Zn [15,16]. 
Flavonoids represent a highly diverse class of secondary metabolites comprising about 9,000 
structures that have been identified to date. They constitute the largest and most important group of 
polyphenolic compounds in plants. These compounds are found in all vascular plants as well as in 




some mosses [17, 18]. The term flavonoid is used to describe plant pigments, mostly derived from 
benzo-γ-pyrone, which is synonymous with chromone (rings A and C in Figure 1) [19,20].  
 

















All flavonoids derive their 15-carbon skeletons (C6–C3–C6) from two basic metabolites, 
malonyl-CoA and p-coumaroyl-CoA. Their crucial biosynthetic reaction is the condensation of three 
molecules of malonyl-CoA with one molecule of p-coumaroyl-CoA to give a chalcone intermediate 
[21]. Chalcones act as the precursors for the vast range of flavonoid derivatives found throughout the 
plant kingdom. Most contain a six-membered heterocyclic ring, formed by Michael-type nucleophilic 
attack of a phenol group on to the unsaturated ketone giving a flavanone [22]. The first committed step 
of the flavonoid pathway is catalyzed by chalcone synthase (CHS; see Scheme 1). Chalcones can then 
be converted into aurones, a subclass of flavonoids found in certain plant species. Beyond CHS, the 
next step shared by most of the flavonoid biosynthesis pathways is catalyzed by chalcone isomerase 
(CHI), which catalyzes a stereospecific ring closure isomerization step to form the 2S-flavanones. The 
flavanones may represent the most important branching point in flavonoid metabolism, because 
isomerization of these compounds yields the others class of flavonoids [23]. However, the chemical 
synthesis is carried out mostly by cyclization and condensation of hydroxyacetophenone. 
Taking into account the chemical nature of the molecule, and the positions of substituents on rings 
A, B, and C, the flavonoids are divided into 14 different groups [24]. Seven of these groups – the 
flavones, flavonols, flavanones, isoflavones, flavanols (catechins), flavanolols, and anthocyanidines – 
are particularly well known [24-27].  
Flavonoids belong to the recently popular phytochemicals, chemicals derived from plant material 
with potentially beneficial effects on human health. The therapeutic effects of many traditional 
medicines may be related in many cases to the presence of these polyphenols [28]. For example, a 
wide variety of pharmacological activities have been reported for these substances, including antiviral 
[29], antiallergic [30], antiplatelet [31], antiestrogenic, anticancerogenic, anti-inflammatory, 
antiproliferative, antiangiogenic, and antioxidant properties, and their ingestion typically produces no 
or very little toxicity [24]. Flavonoids were also reported to act in the gastrointestinal tract, having 
antispasmodic [32], anti-secretory, antidiarrhoeal [33] and antiulcer properties [34]. Considering the 
important role of flavonoids in the prevention or reduction of gastric lesions induced by different 
ulcerogenic agents, this aim of this study was to review the literature on flavonoids with 
gastroprotective activity. The search was carried out on Pubmed, Schifinder School, Sciency Direct 
and NAPRALERT (Acronym for Natural Products ALERT) the data bank of The University of Illinois 
in Chicago, updated to December 2007, using “anti-ulcer flavonoids” as the search term. The 




references found in the search were later consulted for details on the models or mechanism based 
bioassays used for testing flavonoids against peptic ulcers. 
 
Scheme 1. A schematic presentation of the flavonoid biosynthetic pathway showing the 
enzymatic steps leading to the major classes of end products. Enzymes are indicated with 
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Abbreviations: ANR, anthocyanidin reductase; ANS, anthocyanidin synthase (also known as 
leucoanthocyanidin dioxygenase); CHI, chalcone isomerase; CHR, chalcone reductase; CHS, 
chalcone synthase; DFR, dihydroflavonol 4-reductase; FNSI and FNSII, flavone synthase I and II; 
IFR, isoflavone reductase; IFS, isoflavone synthase; LAR, leucoanthocyanidin reductase; GTs, 
glucosyl transferases [21]. 




Flavonoids studied in models that investigate anti-ulcer activity  
In this literature review, it was possible to identify ninety-five flavonoids, whose gastroprotective 
activities cover a full range from inactive through weak activity to active and even strong activity. Of 
the flavonoids found in this study, forty-two were reportedly inactive; however, this inactivity could 
vary widely according to the experimental model, animal, route of administration and the dose. For 
example, flavonols like kaempferol, robinin and dactailin showed no gastroprotective effect in 
experimental models of reserpine [35,36] and restraint stress-induced ulcers in mouse [35], but 
kaempferol at doses of 50 and 100 mg/kg showed gastroprotective activity, and when the dose was 
increased to 250 mg/kg, it showed no activity [37]. Similar results were found for nobeletin, a flavone, 
where doses of 8 and 25 mg/kg protect the gastric mucosa of the rats from injuries induced by ethanol 
and HCl/ethanol, respectively, but it was only weakly active at a dose of 50 mg/kg in model of aspirin-
induced ulcers [38]. Although many of the pharmacological and biochemical actions of flavonoids are 
attributed to their activities as antioxidants [39], this observed inactivity in high doses may be related 
to the capacity of flavonoids to act as pro-oxidants. Thus, flavonoids like quercetin, myricetin and 
kaempferol induce a concentration-dependent decrease of both the nuclear glutathione (GSH) content 
and glutathione S-transferase (GST) activity in a model system of isolated rat liver nuclei, which could 
lead to oxidative DNA damage [40], which in turn may be responsible for their mutagenicity and 
carcinogenicity; this effect may be explained by the pro-oxidant effects of this compounds [40, 41]. 
Nevertheless, the structural features that might determine the pro-oxidant activity of these compounds 
are not well established. 
Chalcones belong to flavonoid class with the largest number of compounds with gastroprotective 
activity. In this review were found thirty-eight,  among which we can mention sophoradin, an 
isoprenyl chalcone, which is present in a Chinese crude drug (the root of Sophora subprostrata) and 
protects the gastric mucosa from lesions induced by pylorus-ligation and water-immersion stress [42, 
43]. Thirty sophoradin analogs have shown anti-ulcer effects in the same ulcer induction models. 
Several chalcones, all having more than one isoprenyloxyl group, exhibited high inhibitory ratios. In 
particular, 2’,4’-dihydroxy-3’-(3-methyl-2-butenyl)-4-(3-methyl-2-butenyloxy) chalcone, 2’-hydroxy-
4,4’-bis(3-methyl-2-butenyloxy) chalcone and 2’-carboxymethoxy-4,4’-bis(3-methyl-2-butenyloxy) 
chalcone (sofalcone), showed strong activity at a dose of 100 mg/kg, with a high percentage of 
inhibition of lesions (70-100%), when compared to other chalcones at the same dose and were as 
potent as sophoradin [42]. Sofalcone is one of these analogs that in addition to its gastroprotective 
effects also accelerates ulcer healing [44]. The mechanisms of action involved in gastric protection are 
increased gastric blood flow, stimulated synthesis of mucosubstances of the gastric mucosa [45] and 
increasing effects on gastric tissue PGs contents [46]. Besides its cytoprotective effects, sofalcone has 
a direct bactericidal effect on H. pylori, with a minimum inhibitory concentration of 55-222 µmol/L, 
anti-urease activity and it reduces the adhesion of this organism to gastric epithelial cells [47,48]. 
When outpatients with peptic ulcers and H. pylori infections were medicated for 7 d with sofalcone 
(100 mg thrice daily) plus the triple therapy with rabeprazole (10 mg twice daily), clarithromycin (200 
mg twice daily) and amoxicillin (750 mg twice daily), sofalcone significantly increased the cure rate of 
H. pylori infections [49]. Therefore flavonoids can be utilized as alternative or additive agents to the 
current therapy in treatment of peptic ulcer induced by H. pylori infection. 




Another flavonoid that appears to exert anti-ulcer activity is monomeric leucocyanidin, a natural 
flavonoid and the major component present in unripe plantain banana (Musa sapientum L. var. 
paradisiaca). It and its synthetic analogues hydroxyethylated leucocyanidin and tetrallylleucocyanidin 
showed protective effects against aspirin-induced gastric erosions in a prophylactic animal model, as 
shown by the absence of mucosal damage and a significant reduction in the ulcer index, when added to 
the diet at 5 mg and 15 mg per day [50,51]. The authors concluded that these compounds may be 
responsible for the displayed anti-ulcer properties and they suggested that the mechanism by which the 
active agent present in plantain banana and its synthetic analogues protects the mucosa is mediated, at 
least in part, by an increase in mucus thickness [51]. 
Another polyphenolic compound with relevant activities is garcinol, a polyisoprenylated 
benzophenone derivative from Garcinia indica, which shows potent free radical scavenging activity in 
three kinds of free radical generating systems. In the hypoxanthine/xanthine oxidase system, 
emulsified garcinol suppressed superoxide anion to almost the same extent as DL-α-tocopherol by 
weight and also suppressed hydroxyl radical more strongly than DL-α-tocopherol in the Fenton 
reaction system. In the H2O2/NaOH/DMSO system, this compound suppressed superoxide anion, 
hydroxyl radical, and methyl radical. Orally administered garcinol prevented acute ulceration in rats 
induced by indomethacin (40-200 mg/kg) and water immersion stress (200 mg/kg) caused by radical 
formation. These results suggested that garcinol might have potential as a free radical scavenger and 
clinical applications as an anti-ulcer drug. Although the mechanism of its anti-ulcer activity is not yet 
understood, garcinol may scavenge reactive oxygen species on the surface of gastric mucosa, thus 
protecting cells from injury [52]. 
A flavonoid that has been studied in some detail is rutin (quercetin-3-rhamnosylglucoside), a 
natural flavone derivative. It has been reported to prevent gastric mucosal ulceration in animal models 
including reserpine [35], acidified ethanol [37] and absolute and 50% ethanol [34,37]. The 
cytoprotective effect of this flavonoid does not appear to be mediated by endogenous prostaglandins 
[53], but its protective effects may be mediated by endogenous platelet-activating factor (PAF), since it 
inhibited dose-dependently the mucosal content of PAF [37]. Another possible mechanism involves 
the  antioxidant properties of rutin, which at a dose of 200 mg/kg has a protective effect against lesions 
induced by 50 % ethanol, probably by reducing the levels of lipoperoxides and increasing the activity 
of the antioxidant enzyme glutathione peroxidase (GSH-Px). However, no significant modifications 
were observed in the gastric non-protein sulfhydryl (SH) content or in the ethanol-induced leukocyte 
infiltrate [34].  
One of the most studied flavonoids is quercetin (3,3’,4’,5,7-pentahydroxyflavone). It protects the 
gastrointestinal mucosa from acute lesions induced by various experiemental models and against 
different necrotic agents, including restraint stress [37,54,55] pylorus-ligation [56], reserpine [35, 
36,55,57], aspirin [54], indomethacin [58], acid-ethanol [37] and ethanol-induced gastric ulcers 
[54,59,60]. Its gastroprotective action mechanism involves endogenous PAF [37], an increase in 
mucus production [58], antihistaminic properties, which decrease histamine levels and reduction of the 
number of ethanol-induced mast cells. It also inhibits H. pylori growth, the formation of acid by 
parietal cells in response to stimulation by histamine and dibutyryl cyclic AMP, as well as the gastric 
H+/K+ proton pump (data not shown in Table 1) [61]. The main mechanism of action for the 
gastroprotective effects of this flavonol are its antioxidant properties, since oral pretreatment with 




quercetin (200 mg/kg) had protective effects in that it significantly reduced the severity of 
ethanol-induced ulcers by inhibition of lipid peroxidation, enhancement in the levels of mucosal non-
protein SH compounds (important antioxidant agents) [59,60] in GSH-Px [59] and superoxide 
dismutase activities, as well as reduction of protein carbonyl compounds [60]. At a dose of 100 mg/kg 
twice daily for 5 days it also decreases lipid peroxidation and plasmatic corticosterone in a restraint 
stress model. This flavonoid, in addition to protecting the gastric mucosa in acute models of ulcer 
induction, when administered chronically both quercetin and naringenin also promote healing of 
gastric ulcers induced by acetic acid, a chronic model of ulcer [62]. The antioxidant mechanism of 
action of flavonoids, especially garcinol, rutin and quercetin, is due mainly the presence in their 
structures of an o-dihydroxy in the B ring (catechol), and additionally a 2,3 double bond in conjugation 
with a 4-oxo function, as well as the presence of hydroxyl groups in positions 3, 5 and 7 [24,63,64] 
Finally, nowadays it is known that NSAIDs, such as piroxicam or aspirin have several adverse 
effects on the gastrointestinal tract and increase the risk of myocardial infarction. However, several 
flavonoids have demonstrated anti-inflammatory properties, without showing any ulcerogenic action 
as a side effect, and thus showing a great advantage in the treatment of peptic ulcers. 
 
Table 1. Flavonoids with gastroprotective activity. 
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Table 1. Cont. 
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Flavonoids represent a highly diverse class of secondary metabolites with potentially beneficial 
effects on human health. These compounds protect the gastrointestinal mucosa from lesions produced 
by various experimental ulcer models and against different necrotic agents. Several mechanisms of 
action may be involved in this protective effect. Quercetin has an anti-secretory mechanism of action. 
This flavonol has antihistaminic properties, thus, decreases histamine levels, as well as preventing the 
release of histamine from gastric mast cells and inhibiting the gastric H+/K+ proton pump, diminishing 
acid gastric secretion. On the other hand chalcones, in particular those with more than one 
isoprenyloxyl group, possess cytoprotective effects, which increase the mucosal blood flow, stimulate 
the synthesis of mucosubstances in the gastric mucosa and increase PGs levels. However, the most 
important mechanism of action responsible for the anti-ulcer activity of flavonoids is their antioxidant 
properties, seen in garcinol, rutin and quercetin, which involves free radical scavenging, transition 
metal ions chelation, inhibition of oxidizing enzymes, increase of proteic and nonproteic antioxidants 
and reduction of lipid peroxidation. These effects are correlated with presence in the structures of an 
o-dihydroxy in the ring B (catechol), and additionally a 2,3 double bond in conjugation with a 4-oxo 
function, as well as the presence hydroxyl groups in positions 3, 5 and 7. Besides the gastroprotective 
activity, sofalcone (a chalcone), quercetin and naringenin (flavanones) accelerate the healing of gastric 
ulcers. In addition, the two first polyphenolic compounds have anti-H. pylori activity and may be 




utilized as an alternative or additive agent to the current therapy. Therefore flavonoids could have an 
ideal more effective and less toxic therapeutic potential for the treatment of gastrointestinal diseases, 
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